Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; The National Health Service Corps Loan Repayment Programs, 65598-65600 [2022-23574]
Download as PDF
<![CDATA[
65598
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
C. Selection Criteria and Process
FDA intends to select participant
CBER and CDER INDs based on the
criteria outlined below. Review of
requests is planned to occur quarterly,
or as needed, depending upon the
requests to participate in the pilot that
are received during the period. FDA
intends to issue a letter to notify each
sponsor of FDA’s decision on their
request to participate within 180 days of
receipt.
In selecting INDs for the pilot
program, FDA intends to consider
factors such as (1) anticipated clinical
benefits of facilitating earlier patient
access to the product, (2) novelty of the
product, (3) complexity of the product
or its manufacturing process, including
technology, (4) sponsor’s overall
manufacturing experience, as well as (5)
sponsor’s experience with the particular
product type, class, or the type of
manufacturing process. FDA may give
additional consideration to less
experienced sponsors. Overall, FDA
intends to seek balance and diversity in
product types, sponsors, and
therapeutic indications to obtain a
variety of relevant experience and
learnings from the pilot.
khammond on DSKJM1Z7X2PROD with NOTICES
D. FDA-Sponsor Interactions During the
Pilot
During this CDRP program, sponsors
will have the ability to discuss their
product development strategies and
goals with FDA review staff during
predesignated Type B meetings and a
limited number of additional CMCfocused discussions. As part of the CMC
readiness pilot, two dedicated CMC
meetings will be granted, and sponsors
will have an opportunity for followup
discussions to address questions arising
from the meeting or meeting minutes, or
if additional clarifications are needed.
In preparation for a meeting, sponsors
should submit written questions along
with a background information package
clearly marked as a ‘‘PDUFA VII CDRP
meeting’’ as part of the cover letter to
enable FDA review staff to address the
questions. The briefing package should
be submitted to the corresponding IND.
Meetings associated with the pilot
should be requested by sponsors. For
additional information on meetings and
other communications between the
sponsors and FDA, see the FDA
guidance for industry entitled ‘‘Formal
Meetings Between the FDA and
Sponsors or Applicants of PDUFA
Products’’ (December 2017) (Ref. 6),
CDER MAPP 6025.6: Good Review
Practice: Management of Breakthrough
Therapy-Designated Drugs and
Biologics (July 29, 2014) (Ref. 7), CBER
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
SOPP 8101: Regulatory Meetings with
Sponsors and Applicants for Drugs and
Biological Products (February 27, 2022)
(Ref. 8), and CBER SOPP 8212.3:
Management of Breakthrough TherapyDesignated Products: Sponsor
Interactions and Status Assessment
Including Rescinding (February 3, 2022)
(Ref. 9).
III. Paperwork Reduction Act of 1995
Collections of information from fewer
than 10 respondents within any 12month period are not subject to the
Paperwork Reduction Act of 1995 (PRA)
(5 CFR 1320.3(c)(4)). To the extent this
information collection involves 10 or
more respondents, this notice refers to
previously approved collections of
information. These collections of
information are subject to review by the
Office of Management and Budget
(OMB) under the PRA (44 U.S.C. 3501–
3521). The collections of information for
NDAs, formal meetings with sponsors
and applicants for PDUFA products,
and PDUFA VII Commitment Letter
have been approved under OMB control
number 0910–0001. The collections of
information for INDs have been
approved under OMB control number
0910–0014. The collections of
information for BLAs have been
approved under OMB control number
0910–0338. The collections of
information pertaining to CGMP
requirements have been approved under
OMB control number 0910–0139. The
collections of information pertaining to
expedited programs for serious
conditions for drugs and biologics and
breakthrough therapy-designation for
drugs and biologics have been approved
under OMB control number 0910–0765.
IV. References
The following references are on
display at the Dockets Management Staff
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852, 240–402–
7500, and are available for viewing by
interested persons between 9 a.m. and 4
p.m., Monday through Friday; they are
also available electronically at https://
www.regulations.gov. FDA has verified
the website addresses, as of the date this
document publishes in the Federal
Register, but websites are subject to
change over time.
1. PDUFA Reauthorization Performance
Goals and Procedures—Fiscal Years 2023
through 2027 at https://www.fda.gov/
media/151712/download.
2. FDA guidance for industry ‘‘Expedited
Programs for Serious Conditions—Drugs
and Biologics’’ (May 2014): https://
www.fda.gov/media/86377/download.
3. FDA guidance for industry ‘‘Providing
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Regulatory Submissions in Electronic
Format—Certain Human Pharmaceutical
Product Applications and Related
Submissions using the eCTD
Specifications’’ (February 2020): https://
www.fda.gov/media/135373/download.
4. FDA guidance for industry ‘‘Process
Validation: General Principles and
Practices’’ (January 2011): https://
www.fda.gov/files/drugs/published/
Process-Validation—General-Principlesand-Practices.pdf.
5. CDER MAPP 5015.13: Quality Assessment
for Products in Expedited Programs (in
clearance).
6. FDA guidance for industry ‘‘Formal
Meetings Between the FDA and Sponsors
or Applicants of PDUFA Products’’
(December 2017): https://www.fda.gov/
media/109951/download.
7. CDER MAPP 6025.6: Good Review
Practice: Management of Breakthrough
Therapy-Designated Drugs and Biologics
(July 2014).
8. CBER SOPP 8101: Regulatory Meetings
with Sponsors and Applicants for Drugs
and Biological Products (February 2022).
9. CBER SOPP 8212.3: Management of
Breakthrough Therapy-Designated
Products: Sponsor Interactions and
Status Assessment Including Rescinding
(February 2022).
Dated: October 25, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–23575 Filed 10–28–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request; The National Health Service
Corps Loan Repayment Programs
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects of the Paperwork Reduction Act
of 1995, HRSA announces plans to
submit an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB). Prior to submitting the ICR to
OMB, HRSA seeks comments from the
public regarding the burden estimate,
below, or any other aspect of the ICR.
DATES: Comments on this Information
Collection Request must be received no
later than December 30, 2022.
SUMMARY:
E:\FR\FM\31OCN1.SGM
31OCN1
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
Submit your comments to
paperwork@hrsa.gov or mail them to
HRSA Information Collection Clearance
Officer, Room 14N136B, 5600 Fishers
Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call Samantha Miller, the acting
HRSA Information Collection Clearance
Officer, at (301) 443–9094.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
The National Health Service Corps
(NHSC) Loan Repayment Programs
(LRP) OMB No. 0915–0127—Revision.
Abstract: The NHSC LRP was
established to assure an adequate
supply of trained primary care health
professionals to provide services in the
neediest Health Professional Shortage
Areas (HPSAs) of the United States. The
NHSC Substance Use Disorder
Workforce LRP and the NHSC Rural
Community LRP were established to
recruit and retain a health professional
workforce with specific training and
credentials to provide evidence-based
substance use disorder treatment in
HPSAs. Under these programs, the
Department of Health and Human
Services agrees to repay the qualifying
educational loans of selected primary
care health professionals. In return, the
health professionals agree to serve for a
specified period of time in an NHSCapproved site located in a federallydesignated HPSA approved by the
Secretary for LRP participants.
The forms utilized by each LRP
include the following: (1) the NHSC LRP
Application, (2) the Authorization for
Disclosure of Loan Information form, (3)
the Privacy Act Release Authorization
form, and if applicable, (4) the
Verification of Disadvantaged
Background form, and (5) the Private
Practice Option form. The first four of
the NHSC LRP forms collect information
that is needed for selecting participants
and repaying qualifying educational
loans. The last referenced form, the
Private Practice Option Form, is needed
to collect information for all
participants who have applied for that
service option.
NHSC-approved sites are health care
facilities that provide comprehensive
outpatient, ambulatory, primary health
care services to populations residing in
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
HPSAs. Related in-patient services may
be provided by NHSC-approved Critical
Access Hospitals and Indian Health
Service hospitals. In order to become an
NHSC-approved site, new sites must
submit a Site Application for review
and approval. Existing NHSC-approved
sites are required to complete a Site
Recertification Application every 3
years in order to maintain their NHSCapproved status. Both the NHSC Site
Application and Site Recertification
Application request information on the
clinical service site, sponsoring agency,
recruitment contact, staffing levels,
service users, charges for services,
employment policies, and fiscal
management capabilities. Assistance in
completing these applications may be
obtained through the appropriate State
Primary Care Offices and the NHSC. The
information collected on the
applications is used for determining the
eligibility of sites for the assignment of
NHSC health professionals and to verify
the need for NHSC clinicians. NHSC
service site approval is valid for 3 years.
Need and Proposed Use of the
Information: The need and purpose of
this information collection is to assess
an LRP applicant’s eligibility and
qualifications for the LRP, and to obtain
information for NHSC site applicants.
The NHSC LRP application asks for
personal, professional, and financial/
loan information.
The proposed revisions in this ICR
include asking applicants to provide
their educational information on the
completion of post graduate training.
The NHSC will use this information to
identify graduates or completers of the
following HRSA-funded programs: the
Primary Care Training and
Enhancement: Training Primary Care
Champions Program, the Addiction
Medicine Fellowship, the Teaching
Health Center Graduate Medical
Education Program, the Advanced
Nursing Education Nurse Practitioner
Residency Program, or the Advanced
Nursing Education Nurse Practitioner
Residency Integration Program. To
identify the graduates or completers of
these HRSA-funded programs, the
NHSC will require applicants to
respond to the following additional
questions:
(1) Have you completed a post
graduate training?
(2) Applicants who selected ‘‘yes’’ to
the question above are required to
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
65599
submit the National Practitioner
Identifier number.
(3) Further, if applicable, applicants
are asked to enter the residency
identification number and their
residency completion certificate, if
available.
NHSC policy requires behavioral
health providers to practice in a
community-based setting that provides
access to comprehensive behavioral
health services. Accordingly, for those
sites seeking to be assigned behavioral
health NHSC participants, additional
site information will be collected from
an NHSC Comprehensive Behavioral
Health Services Checklist. NHSC sites
that do not directly offer all required
behavioral health services must
demonstrate a formal affiliation with a
comprehensive, community-based
primary behavioral health setting or
facility to provide these services.
Likely Respondents: Likely
respondents include: (1) Licensed
primary care medical, dental, and
mental and behavioral health providers
who are employed or seeking
employment, and are interested in
serving underserved populations; (2)
health care facilities interested in
participating in the NHSC and becoming
an NHSC-approved service site; and (3)
NHSC sites providing behavioral health
care services directly, or through a
formal affiliation with a comprehensive
community-based primary behavioral
health setting or facility providing
comprehensive behavioral health
services.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
E:\FR\FM\31OCN1.SGM
31OCN1
65600
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Total
responses
Average
burden
per response
(in hours)
Total
burden hours
NHSC LRP Application ........................................................
Authorization for Disclosure of Loan Information Form .......
Privacy Act Release Authorization Form .............................
Verification of Disadvantaged Background Form ................
Private Practice Option Form ..............................................
NHSC Comprehensive Behavioral Health Services Checklist .....................................................................................
NHSC Site Application (including recertification) ................
9,020
7,150
303
660
330
1
1
1
1
1
9,020
7,150
303
660
330
1.00
.10
.10
.50
.10
9,020
715
30.0
330
33
4,400
4,070
1
1
4,400
4,070
.13
.50
572
2,035
Total ..............................................................................
25,933
........................
25,933
........................
12,735
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022–23574 Filed 10–28–22; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel Member
Conflict: Cell Biology, Biochemistry,
and Aging, November 21, 2022, 12:00
p.m. to November 21, 2022, 6:00 p.m.,
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
which was published in the Federal
Register on October 24, 2022, 87 FR
64241 Doc 2022–23066.
This meeting is being amended to
change the meeting start date from
November 21, 2022, to November 22,
2022. The meeting is closed to the
public.
Dated: October 26, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23638 Filed 10–28–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
17:15 Oct 28, 2022
Jkt 259001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Respiratory Sciences.
Date: November 29–30, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Imoh S Okon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–347–8881, imoh.okon@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Conflicts in hepatology,
pharmacology and toxicology.
Date: November 29, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Frederique Yiannikouris,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, 301–594–3313,
frederique.yiannikouris@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–21–
120: Global Infectious Disease Research
Training Program [D43 Clinical Trial
Optional].
Date: November 29, 2022.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
Contact Person: Dayadevi Jirage, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4422,
Bethesda, MD 20892, (301) 867–5309,
jiragedb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention and
Immunotherapy.
Date: November 30, 2022.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laurie Ann Shuman Moss,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, laurie.shumanmoss@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Computational, Modeling, and
Biodata Management.
Date: November 30, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marie-Jose Belanger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm 6188 MSC
7804, Bethesda, MD 20892, 301–435–1267,
belangerm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23608 Filed 10–28–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Pages 65598-65600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23574]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request; The National Health
Service Corps Loan Repayment Programs
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement for opportunity for public
comment on proposed data collection projects of the Paperwork Reduction
Act of 1995, HRSA announces plans to submit an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the
public regarding the burden estimate, below, or any other aspect of the
ICR.
DATES: Comments on this Information Collection Request must be received
no later than December 30, 2022.
[[Page 65599]]
ADDRESSES: Submit your comments to [email protected] or mail them to
HRSA Information Collection Clearance Officer, Room 14N136B, 5600
Fishers Lane, Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
draft instruments, email [email protected] or call Samantha Miller,
the acting HRSA Information Collection Clearance Officer, at (301) 443-
9094.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: The National Health Service
Corps (NHSC) Loan Repayment Programs (LRP) OMB No. 0915-0127--Revision.
Abstract: The NHSC LRP was established to assure an adequate supply
of trained primary care health professionals to provide services in the
neediest Health Professional Shortage Areas (HPSAs) of the United
States. The NHSC Substance Use Disorder Workforce LRP and the NHSC
Rural Community LRP were established to recruit and retain a health
professional workforce with specific training and credentials to
provide evidence-based substance use disorder treatment in HPSAs. Under
these programs, the Department of Health and Human Services agrees to
repay the qualifying educational loans of selected primary care health
professionals. In return, the health professionals agree to serve for a
specified period of time in an NHSC-approved site located in a
federally-designated HPSA approved by the Secretary for LRP
participants.
The forms utilized by each LRP include the following: (1) the NHSC
LRP Application, (2) the Authorization for Disclosure of Loan
Information form, (3) the Privacy Act Release Authorization form, and
if applicable, (4) the Verification of Disadvantaged Background form,
and (5) the Private Practice Option form. The first four of the NHSC
LRP forms collect information that is needed for selecting participants
and repaying qualifying educational loans. The last referenced form,
the Private Practice Option Form, is needed to collect information for
all participants who have applied for that service option.
NHSC-approved sites are health care facilities that provide
comprehensive outpatient, ambulatory, primary health care services to
populations residing in HPSAs. Related in-patient services may be
provided by NHSC-approved Critical Access Hospitals and Indian Health
Service hospitals. In order to become an NHSC-approved site, new sites
must submit a Site Application for review and approval. Existing NHSC-
approved sites are required to complete a Site Recertification
Application every 3 years in order to maintain their NHSC-approved
status. Both the NHSC Site Application and Site Recertification
Application request information on the clinical service site,
sponsoring agency, recruitment contact, staffing levels, service users,
charges for services, employment policies, and fiscal management
capabilities. Assistance in completing these applications may be
obtained through the appropriate State Primary Care Offices and the
NHSC. The information collected on the applications is used for
determining the eligibility of sites for the assignment of NHSC health
professionals and to verify the need for NHSC clinicians. NHSC service
site approval is valid for 3 years.
Need and Proposed Use of the Information: The need and purpose of
this information collection is to assess an LRP applicant's eligibility
and qualifications for the LRP, and to obtain information for NHSC site
applicants. The NHSC LRP application asks for personal, professional,
and financial/loan information.
The proposed revisions in this ICR include asking applicants to
provide their educational information on the completion of post
graduate training. The NHSC will use this information to identify
graduates or completers of the following HRSA-funded programs: the
Primary Care Training and Enhancement: Training Primary Care Champions
Program, the Addiction Medicine Fellowship, the Teaching Health Center
Graduate Medical Education Program, the Advanced Nursing Education
Nurse Practitioner Residency Program, or the Advanced Nursing Education
Nurse Practitioner Residency Integration Program. To identify the
graduates or completers of these HRSA-funded programs, the NHSC will
require applicants to respond to the following additional questions:
(1) Have you completed a post graduate training?
(2) Applicants who selected ``yes'' to the question above are
required to submit the National Practitioner Identifier number.
(3) Further, if applicable, applicants are asked to enter the
residency identification number and their residency completion
certificate, if available.
NHSC policy requires behavioral health providers to practice in a
community-based setting that provides access to comprehensive
behavioral health services. Accordingly, for those sites seeking to be
assigned behavioral health NHSC participants, additional site
information will be collected from an NHSC Comprehensive Behavioral
Health Services Checklist. NHSC sites that do not directly offer all
required behavioral health services must demonstrate a formal
affiliation with a comprehensive, community-based primary behavioral
health setting or facility to provide these services.
Likely Respondents: Likely respondents include: (1) Licensed
primary care medical, dental, and mental and behavioral health
providers who are employed or seeking employment, and are interested in
serving underserved populations; (2) health care facilities interested
in participating in the NHSC and becoming an NHSC-approved service
site; and (3) NHSC sites providing behavioral health care services
directly, or through a formal affiliation with a comprehensive
community-based primary behavioral health setting or facility providing
comprehensive behavioral health services.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose, or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install, and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this Information Collection Request are summarized in the table below.
[[Page 65600]]
Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
NHSC LRP Application............ 9,020 1 9,020 1.00 9,020
Authorization for Disclosure of 7,150 1 7,150 .10 715
Loan Information Form..........
Privacy Act Release 303 1 303 .10 30.0
Authorization Form.............
Verification of Disadvantaged 660 1 660 .50 330
Background Form................
Private Practice Option Form.... 330 1 330 .10 33
NHSC Comprehensive Behavioral 4,400 1 4,400 .13 572
Health Services Checklist......
NHSC Site Application (including 4,070 1 4,070 .50 2,035
recertification)...............
-------------------------------------------------------------------------------
Total....................... 25,933 .............. 25,933 .............. 12,735
----------------------------------------------------------------------------------------------------------------
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-23574 Filed 10-28-22; 8:45 am]
BILLING CODE 4165-15-P
